The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials

BACKGROUND: Patient-reported outcome measures (PROMs) are often used in clinical research, but little is known about their performance as longitudinal outcomes. METHODS: We used data from ASCEND, a large SPMS trial (n = 889), to investigate changes on the Short Form Health Survey 36 (SF-36 v2) and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Strijbis, Eva MM, Repovic, Pavle, Mostert, Jop, Bowen, James D, Uitdehaag, Bernard MJ, Cutter, Gary, Koch, Marcus W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315187/
https://www.ncbi.nlm.nih.gov/pubmed/35876467
http://dx.doi.org/10.1177/13524585221105465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315187/
https://www.ncbi.nlm.nih.gov/pubmed/35876467
http://dx.doi.org/10.1177/13524585221105465

Ejemplares similares